Sekisui Diagnostics

Sekisui Diagnostics, through its 'BioProduction' division, is a specialized, fermentation-focused CDMO serving the global biopharma and diagnostics industries. The company leverages deep expertise in microbial systems (E. coli, yeast) to develop and manufacture recombinant proteins and specialty biochemicals for therapeutic, pharmaceutical, and diagnostic applications. Recently completing a £15.7 million expansion of its UK cGMP facility, the company is positioned for growth in the outsourced bioproduction market. It operates as a business unit within the larger Sekisui Chemical conglomerate, providing stability and scale.

Microbial fermentation platform specializing in E. coli and yeast systems, with full downstream processing capabilities including protein purification, formulation, lyophilization, and analytical testing.

Competes with large, diversified CDMOs (e.g., Lonza, Catalent) and smaller niche microbial fermentation specialists. Differentiation is based on over 40 years of specific expertise in microbial protein production, a focused service offering, and the financial backing of the Sekisui Chemical parent company.